Induced pluripotent stem cells (iPSCs) are generated by introducing four transcription factors into adult cells, reprogramming them into a pluripotent state similar to embryonic stem cells. Shinya Yamanaka pioneered this technique in 2006, identifying the key factors Oct4, Sox2, c-Myc, and Klf4. While this breakthrough provided a new source of pluripotent cells without ethical concerns, reprogramming efficiency was initially low and incorporated the transcription factors into the genome, posing risks. Alternative methods now aim to improve iPSC generation through chemicals or non-integrating vectors.
Induced pluripotent stem cells (iPSCs) are generated by introducing four transcription factors into adult cells, reprogramming them into a pluripotent state similar to embryonic stem cells. Shinya Yamanaka pioneered this technique in 2006, identifying the key factors Oct4, Sox2, c-Myc, and Klf4. While this breakthrough provided a new source of pluripotent cells without ethical concerns, reprogramming efficiency was initially low and incorporated the transcription factors into the genome, posing risks. Alternative methods now aim to improve iPSC generation through chemicals or non-integrating vectors.
Induced pluripotent stem cells (iPSCs) are generated by introducing four transcription factors into adult cells, reprogramming them into a pluripotent state similar to embryonic stem cells. Shinya Yamanaka pioneered this technique in 2006, identifying the key factors Oct4, Sox2, c-Myc, and Klf4. While this breakthrough provided a new source of pluripotent cells without ethical concerns, reprogramming efficiency was initially low and incorporated the transcription factors into the genome, posing risks. Alternative methods now aim to improve iPSC generation through chemicals or non-integrating vectors.
Induced pluripotent stem cells (iPSCs) are generated by introducing four transcription factors into adult cells, reprogramming them into a pluripotent state similar to embryonic stem cells. Shinya Yamanaka pioneered this technique in 2006, identifying the key factors Oct4, Sox2, c-Myc, and Klf4. While this breakthrough provided a new source of pluripotent cells without ethical concerns, reprogramming efficiency was initially low and incorporated the transcription factors into the genome, posing risks. Alternative methods now aim to improve iPSC generation through chemicals or non-integrating vectors.
Download as PPTX, PDF, TXT or read online from Scribd
Download as pptx, pdf, or txt
You are on page 1/ 15
INDUCED
PLURIPOTENT STEM CELLS
EMBRYONIC STEM CELLS
Embryonic stem cells(ES cells)
arepluripotent stem cellsderived from theinner cell massof ablastocyst, an early-stage preimplantationembryo. Humanembryosreach theblastocyst stage 45 days postfertilization, at which time they consist of 50150 cells. Isolating theembryoblast orinner cell mass(ICM) results in destruction of the blastocyst,which raises ethical issues.
Embryonic stem cells, derived from the
blastocyst stage early mammalian embryos, are distinguished by their ability to differentiate into any cell type and by their ability to propagate
INDUCED PLURIPOTENT STEM CELLS
Induced pluripotent stem cells(also known
asiPScells oriPSCs) are a type ofpluripotentstem cellthat can be generated directly from adult cells. The iPSC technology was pioneered byShinya Yamanakas lab inKyoto,Japan in 2006. He showed that the introduction of four specific genes encodingtranscription factorscould convert adult cells into pluripotent stem cells. He was awarded the 2012 Nobel Prize along with SirJohn Gurdonfor the discovery that mature cells can be reprogrammed to become pluripotent.
VECTOR
Retroviruses were used for the delivery
of the target genes.
PRODUCTION OF IPSCs
hypothesis was that genes important to
embryonic stem cell function might be able to induce an embryonic state in adult cells. They began by choosing twenty-four genes that were previously identified as important in embryonic stem cells, and used retroviruses to deliver these genes to fibroblasts from mice. used retroviruses to deliver these genes to fibroblasts from mice. The mouse fibroblasts were engineered so that any cells that reactivated the ESC-specific gene, Fbx15, could be isolated using antibiotic selection.
Upon delivery of all twenty-four factors,
colonies emerged that had reactivated the Fbx15 reporter, resembled ESCs, and could propagate indefinitely. They then narrowed their candidates by removing one factor at a time from the pool of twenty-four. By this process, they identified four factors, Oct4, Sox2, cMyc, and Klf4, which as a group were both necessary and sufficient to obtain ESC-like colonies
PROCEDURE FOLLOWED :
TRANSCRIPTION FACTORS
Oct3/4 :Oct-3/4 is one of the family
ofoctamer ("Oct") transcription factors and plays a crucial role in maintaining pluripotency. The absence of Oct-3/4 in Oct-3/4+cells, such asblastomeresandembryonic stem cells leads to spontaneoustrophoblast differentiation. Thus, presence of Oct-3/4 thus gives rise to the pluripotency and differentiation potential of embryonic stem cells.
Sox2: The Sox family of genes is associated with
maintaining pluripotency similar to Oct-3/4, although it is associated with multipotent and unipotent stem cells in contrast with Oct-3/4, which is exclusively expressed in pluripotent stem cells. Klf4: Kruppel-like factor 4(KLF4) is a member of the KLFfamilyoftranscription factorsand regulatesproliferation,differentiation,apoptosis andsomatic cell reprogramming. c-Myc: encodes transcription factors.
PROBLEMS ENCOUNTERED:
Low efficiency: in general, the conversion to
iPSCs cells has been incredibly low. For example, the rate at whichsomaticcells were reprogrammed into iPS cells in Yamanaka's original mouse study was 0.010.1%. Genomic Insertion: genomic integration of thetranscription factorslimits the utility of thetranscription factorapproach because of the risk of mutations being inserted into the target cells genome. Tumours: on account of retroviruses and c-Myc genes
ALTERNATIVES
Using chemicals: Avoid the problem of genomic
integration, they raise reprogramming efficiency. Key studies using such strategy were conducted in 2008. Melton et al. studied the effects of histone deacetylase (HDAC) inhibitor valproic acid. They found that it increased reprogramming efficiency 100-fold (compared to Yamanakas traditionaltranscription factormethod).[25]The researchers proposed that this compound was mimicking the signaling that is usually caused by thetranscription factorc-Myc. Use of alternate vectors like, adenoviruses, plasmids or naked DNA.
